Stay updated on Recombinant Prourokinase for Acute Pulmonary Embolism Clinical Trial

Sign up to get notified when there's something new on the Recombinant Prourokinase for Acute Pulmonary Embolism Clinical Trial page.
Latest website image capture
Clouds background image

Latest updates to the Recombinant Prourokinase for Acute Pulmonary Embolism Clinical Trial page

  1. Check
    today
    Change Detected
    Summary
    A banner announces NIH’s website transition and says the term “Super Intelligence” may appear in place of “Artificial Intelligence” across NIH content.
    Difference
    1%
    Check dated 2026-10-24T23:14:34.000Z thumbnail image
  2. Check
    7 days ago
    Change Detected
    Summary
    The footer now identifies the site as revision v3.7.2 instead of v3.7.1.
    Difference
    0.2%
    Check dated 2026-10-17T23:33:33.000Z thumbnail image
  3. Check
    14 days ago
    Change Detected
    Summary
    The ClinicalTrials.gov error page shows the site revision changing from v3.7.0 to v3.7.1.
    Difference
    0.2%
    Check dated 2026-10-10T23:33:13.000Z thumbnail image
  4. Check
    35 days ago
    Change Detected
    Summary
    The page now displays a 403 Forbidden error, replacing the study content with an access-denied message. This indicates the study record at this URL is currently inaccessible.
    Difference
    19%
    Check dated 2026-09-19T22:24:48.000Z thumbnail image
  5. Check
    56 days ago
    Change Detected
    Summary
    A revision label on the page updated from v3.6.5 to v3.6.6, representing a minor version update to the page.
    Difference
    0.1%
    Check dated 2026-08-29T20:59:30.000Z thumbnail image
  6. Check
    77 days ago
    Change Detected
    Summary
    The page now shows Revision: v3.6.5, replacing the previous Revision: v3.6.4. This indicates a software or UI update to the page.
    Difference
    0.0%
    Check dated 2026-08-08T18:13:09.000Z thumbnail image

Stay in the know with updates to Recombinant Prourokinase for Acute Pulmonary Embolism Clinical Trial

Enter your email address, and we'll notify you when there's something new on the Recombinant Prourokinase for Acute Pulmonary Embolism Clinical Trial page.